MISMATCH REPAIR DEFICIENCY
Clinical trials for MISMATCH REPAIR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves and immunotherapy join forces against deadly brain tumor
Disease control Not yet recruitingThis early-stage study tests a new way to treat a type of aggressive brain cancer (glioblastoma) that has come back after standard treatment. It combines a focused ultrasound device that opens the blood-brain barrier with an immunotherapy drug called pembrolizumab. The main goal …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New immunotherapy may let some women skip surgery for endometrial cancer
Disease control Not yet recruitingThis study tests whether a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) can shrink or eliminate tumors in women with a specific type of endometrial cancer (mismatch repair-deficient). The goal is to see if these drugs can be an alternative to surgery. Abo…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated May 26, 2026 11:55 UTC